•   
  •   
  •   

Opinion Editorial.vaccines against COVID-19: "Soft Power" and Eye Powder

14:20  12 june  2021
14:20  12 june  2021 Source:   lemonde.fr

The 6 reasons Americans aren’t getting vaccinated

  The 6 reasons Americans aren’t getting vaccinated This is the challenge America has to overcome to get back to a post-pandemic normal.America’s vaccine campaign has collapsed from its previous highs. While at one point in mid-April more than 3 million people received the shot each day, now only around 1.2 million are now — a rate that’s less than half of what it was at the peak. So the US might not make President Joe Biden’s goal to vaccinate 70 percent of adults by July Fourth: At the current rates, roughly 175 million adults will get at least their first shots by Independence Day, falling short of the nearly 180 million needed.

The gift announced to the G7 of a billion doses by mid-2022 does not make a vaccine a "global public good" . Rich countries are still missing a true, unitary and coherent country, for equitable access to anti-Covid vaccines.

Editorial of the "World". It is virtuous emulations, and it is not going out of it. The competition, under cover of "soft power", the Powers of the G7 on the distribution of anti-Covid-19 vaccines to the countries that are cruelly under the second category.

united since Friday, June 11 in Carbis Bay, in Great Britain, the leaders of this rich and democratic country club have indicated that they would commit together one billion doses, in order to "vaccinate the world ". President Joe Biden promised that the United States would provide half. To not be left out, British Prime Minister Boris Johnson advanced 100 million doses, such as Canada. The European Union (EU) refrained from overbidding, camped on its mother posture, since it is the continent that exports the most vaccines since the beginning of the inoculation campaign.

First in line, still no shot: Surprising number of hospital workers refuse vaccines

  First in line, still no shot: Surprising number of hospital workers refuse vaccines Hospitals grapple with workers who cite everything from past COVID-19 infection to religion to the experimental vaccines in saying no to the shot.Nevens’ hospital in the Houston area was among the first in the nation to require the vaccine and remains one of a handful doing so. Houston Methodist set an early deadline for its 1,255 executives and managers and Nevens was one of only two managers who failed to step up. Other workers have until June 7 to comply.

at G7, promises of vaccine donations to poor countries to counter Chinese and Russian influence here for ads. A further examination of these commitments, and in particular the delivery schedule, illuminates the situation of a less flattering light. Most of these countries have started their national vaccination campaign at the end of the year 2020. Some have, very early, ordered, and therefore grabbed, hundreds of millions of doses to the pharmaceutical laboratories whose work on the vaccine against the Covid-19 seemed promising and that they usually subsidized. While the United States and the United Kingdom began to vaccinate their population, it appeared that they would have many more doses than they need in the short term. EU countries, at this stage, were still struggling with a serious supply problem.

Bar graph memorial, motivated by $1 million, summer school: News from around our 50 states

  Bar graph memorial, motivated by $1 million, summer school: News from around our 50 states How the COVID-19 pandemic is affecting every stateStart the day smarter. Get all the news you need in your inbox each morning.


Video: Covid-19: Vaccination could be extended over the past 16 years in June (Europe 1)

Charges of "vaccinal nationalism" It took six months in Washington and London to start interest to the rest of the world. Once the target of 50% of the Americans vaccinated, the Biden administration became aware of the damage that the accusations of "vaccinal nationalism" could inflict, while China unfolded its own. At the same time, the ravages of a new variant of the virus in India, brutally placed the spotlight on the global immunization inequality.

While Europeans, more sensitive since the beginning of the issue of equitable vaccine access, highlights their own equation - as many vaccines exported and vaccines administered within the EU - the United States At the end of April, offered to deliver 60 million doses of Astrazeneca, vaccine which, in any event, was not allowed at home. Then, in May, they proposed a temporary lifting of patents.

Fact check: Post misleads on effectiveness of J&J COVID-19 vaccine in older adults

  Fact check: Post misleads on effectiveness of J&J COVID-19 vaccine in older adults A post online from anti-vaccination group Physicians for Informed Consent claims J&J COVID-19 vaccine ineffective in older adults. This is false.Use of the one-dose shot was paused for several weeks but lifted on April 23 after both the U.S. Food and Drug Administration and the U.S. Centers for Disease Control found the vaccine was overall safe and effective.

VACCINS Against COVID-19: The Biden Administration supports the suspension of patents against "extraordinary circumstances"

This proposal, inapplicable immediately because of the long-term negotiations to the World Trade Organization, was a screen of smoke, which took Europeans to reverse. It paved the way for a regrettable transatlantic controversy on the comparative merits of the sharing of vaccines, technology transfers and patent lifting, while they are complementary and should be the subject of a coherent and unitary strategy.

The donation of one billion doses deliverable in the twelve months does not constitute such a strategy or does the vaccine a "global public good". If it is a mission that this G7 should join, it is to give oneself the ambition and the means to rid the planet of this devastating pandemic, thanks to a distribution and a fair production of the vaccine.

Companies give vaccines to workers, boosting Japan's rollout .
TOKYO (AP) — Thousands of Japanese companies began distributing COVID-19 vaccines to workers and their families Monday in an employer-led drive reaching more than 13 million people that aims to rev up the nation's slow vaccine rollout. Yuka Daimaru, among the Suntory workers getting the shot on a sprawling office floor, was visibly relieved after spending more than a year worrying about the coronavirus. “I was nervous, but it didn’t hurt as much as I thought it would,” she said. “Now I don’t have to worry as much on commuter trains or at meetings.

usr: 1
This is interesting!